Linneo Health appoints Gerardo Gorostiza as Chief Financial and Strategy Officer
Madrid, Spain, 21 July 2022: Linneo Health, a global leader in the research, cultivation and supply of cannabis to improve human health and wellbeing, today announces the appointment of Gerardo Gorostiza as Chief Financial and Strategy Officer.
Gerardo possesses an impressive track record of success leading the financial and strategy functions of a number of multinational businesses, both private and publicly listed, with a specialty in corporate finance, strategic planning, business transformation and corporate development.
He brings experience from roles at Uralita, Adveo and Grupo Costa Food, and as a consultant with PricewaterhouseCoopers. Most recently, Gerardo was CFO and subsequently CEO of Juan Luna, a leading Spanish food processing company, where he played an integral role in the professionalisation of the company and its subsequent sale to a top industrial player.
Gerardo holds an Executive MBA from the IE Business School in Madrid, Spain, and qualified as an Industrial Engineer with the Universidad del País Vasco, Spain.
Don Bellamy, Chief Executive Officer of Linneo Health, commented: “We are delighted to welcome Gerardo to Linneo Health as Chief Financial and Strategy Officer. He brings a wealth of experience and knowledge, and his strategic mindset and leadership skills will be invaluable to Linneo as we continue to build on our success and growth as the leading provider of medicinal cannabis, for the benefit of patients.”
Gerardo Gorostiza, Chief Financial and Strategy Officer of Linneo Health, commented: “Linneo Health’s fully integrated platform, enabling the research, manufacture and supply of the highest quality medicinal cannabis, puts the company in a prime position to grow at scale as this market matures. I am looking forward to working with Don and the team to maintain Linneo’s leading position and continue its expansion.”
Enquiries:
Linneo Health
Don Bellamy, CEO
linneo@linneohealth.com
Tel: +34 91 700 20 90
Consilium Strategic Communications
Amber Fennell / David Daley / Maya Bennison
Linneo@consilium-comms.com
Tel: +44 (0) 20 3709 5700
About Linneo Health
Linneo Health is a global leader in the research, EU-GMP certified manufacture and supply of medicinal cannabis flowers, extracts and products to pharmaceutical partners developing innovative cannabis-based therapies for patients in need. The world’s only vertically integrated medicinal cannabis supplier, no other company has Linneo’s 90-year heritage in the manufacturing, handling and movement of controlled substances. Linneo is optimally positioned to address the needs of its customers through every stage of product development, regulation and handling.
Linneo Health is setting the benchmark for standards and customer service in medicinal cannabis. Through ongoing investment in one of the most advanced quality control laboratories in Europe, and by applying industry-leading cultivation techniques, Linneo is the trusted partner to address the needs of customers today and, with significant expansion capabilities, the demands of tomorrow. With an unrivalled focus on quality and driven by the firm belief that people around the world deserve to be treated with cannabis medicine of the highest standard, Linneo brings cutting edge innovation in medicinal cannabis to partners, to deliver better patient outcomes and improve lives.
www.linneohealth.com